The firm is developing blood-based early cancer detection tests for a variety of indications, including colorectal cancer and lung cancer.
According to DOJ, the company provided consulting services at below market value to certain health care providers that referred patients to NeoGenomics for lab testing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results